Key points from article :
A new type of antibody test can give more detailed information on how our immune systems react to viruses and bacteria.
Currently developing and evaluating a new diagnostic platform with the name AVA (Attana Virus Analytics).
To study individuals' immune response to SARS Cov-2 and the bacteria Clostridium tetani.
Enables easy sampling where results can be ready in 15 minutes.
More reliable measurements of COVID-19 antibodies
"This should help decide who needs to take vaccine and how well an individual has responded to a vaccine," -Ian Nicholls, professor of chemistry at Linnaeus University.
Not only ensures that an antibody test is correct, it can also offer insights concerning the sustainability of immunity.
By collecting data on the quantity and quality of antibodies in a sample, an immunity development profile can be established.
AVA also offers laboratories the opportunity to validate already existing test results with great accuracy.
Research by Linnaeus University.
